Abstract
Long-term effects of cornstarch (CS) therapy on biochemical values and physical growth in children with type I glycogen storage disease (GSD I) were compared to those of children receiving continuous nocturnal nasogastric glucose feedings (CNG). Only patients who had received more than 5 years of dietary therapy (either CS or CNG) were evaluated. Six patients (five female, age 13.5 years±1.3, range 11.7–16.5 years) received CS (1.75–2.5 g/kg, four times daily) and seven patients (five female, age 9.6±2.5 years, range 7.3–14.8 years) received CNG. Blood glucose, lactate, cholesterol and triglyceride levels were not significantly different between the two methods of treatment. All patients maintained linear growth rates normal for their age. The standard deviation score of height after 6.7±1.6 years (range 5–9 years) of CS treatment was −1.29±0.59 and after 8.8±2.4 years (range 7–14 years) of CNG was −1.24±0.63. These values did not differ significantly from each other or from the target height, an estimate of genetic potential for height as determined from parental heights. With the exceptions of diarrhea, increased flatulence and excess weight gain, there were no adverse effects of CS after 9 years of treatment. Our data suggests that cornstarch is a simple, effective and safe therapy for GSD I.
Similar content being viewed by others
Abbreviations
- CNG:
-
continuous nocturnal glucose findings
- CS:
-
cornstarch
- GSDI:
-
type 1 glycogen storage disease
References
Chen YT, Cornblath M, Sidbury JB (1984) Cornstarch therapy in type I glycogen storage disease. N Engl J Med 310: 171–175
Food and Nutrition Board (1989) Recommended dietary allowances, 10th edn. National Academy Press, Washington D.C.
Gatti R, Lamedica G, Di Rocco M, Massocco D, Marchese N, Borrone C (1986) Long-term cornstarch therapy in glycogen storage disease types I, Ib and III. J Inherited Metab Dis [9 Suppl] 2: 280–283
Gitzelmann R, Hirsig J (1986) Infant dumping syndrome: reversal of symptoms by feeding uncooked starch. Eur J Pediatr 145: 504–506
Greene HL, Slonim AE, O'Neill JA Jr, Burr IM (1976) Continuous nocturnal intragastric feeding for management of type I glycogen storage disease. N Engl J Med 294: 423–425
Gremse DA, Bucuvalas JC, Balistreri WF (1990) Efficacy of cornstarch therapy in type III glycogen storage disease. Am J Clin Nutr 52: 671–674
Hamill PVV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM (1979) Physical growth: national center for health statistics percentiles. Am J Clin Nutr 32: 607–629
Harland BF, Oberleas D (1986) Anion-exchange method for determination of phytate in foods: collaborative study. J Assoc Off Anal Chem 69: 667–670
Harland BF, Oberleas D (1987) Phytate in foods. World Rev Nutr Diet 52: 235–259
Lozano RL, Chalew SA, Kowarski AA (1990) Cornstarch ingestion after oral glucose loading: effect on glucose concentrations, hormone response, and symptoms in patients with postprandial hypoglycemia syndrome. Am J Clin Nutr 52: 667–670
Rose SR, Chrousos G, Cornblath M, Sidbury JB (1986) Management of postoperative nesidioblastosis with zinc protamine glucagon and oral starch. J Pediatr 108: 97–100
Sloan HR, Zipt WB (1983) Cornstarch therapy of glycogen storage disease type I (GSD-I) Pediatr Res 17: 220A
Smit GPA, Berger R, Potasnick R, Moses SW, Fernandes J (1984) The dietary treatment of children with type I glycogen storage disease with slow release carbohydrate. Pediatr Res 18: 879–881
Tanner JM, Goldstein H, Whitehous RH (1970) Standards for children's height at ages 2–9 years allowing for height of parents. Arch Dis Child 45: 755
Ullrich K, Schmidt H, Van Teeffelen-Heithoff A (1988) Glycogen storage disease type I and III and pyruvate carboxylase deficiency: results of long-term treatment with uncooked cornstarch. Acta Paediatr Scand 77: 531–536
Wolfsdorf JI, Keller RJ, Landy H, Crigler JF Jr (1990) Glucose therapy for glycogenosis type I in infants: comparison of intermittent uncooked cornstarch and continuous overnight glucose feedings. J Pediatr 117: 384–391
Wolfsdorf JI, Rudlin CR, Crigler JF Jr (1990) Physical growth and development of children with type I glycogen storage disease: comparison of the effects of long-term use of dextrose and uncooked cornstarch. Am J Clin Nutr 52: 1051–1057
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chen, Y.T., Bazzarre, C.H., Lee, M.M. et al. Type I glycogen storage disease: Nine years of management with cornstarch. Eur J Pediatr 152 (Suppl 1), 56–59 (1993). https://doi.org/10.1007/BF02072090
Issue Date:
DOI: https://doi.org/10.1007/BF02072090